Carvolix Receives Financing to Accelerate Commercialization of TAVIpilot Software

August 18, 2026—Claret Capital Partners announced it has made an investment of €30 million in Carvolix.

Versa Vascular Appoints Bill Shields as CEO

August 14, 2026—Versa Vascular, Inc. announced the appointment of Bill Shields as Chief Executive Officer.

Jupiter Endovascular Appoints Dr. Catalin Toma as Chief Medical Officer

August 13, 2026—Jupiter Endovascular Inc., announced the appointment of interventional cardiologist Catalin Toma, MD, as Chief Medical Officer.

Bracco VueJect Ultrasound Contrast Delivery System Receives FDA Clearance, Health Canada Authorization

August 12, 2026—Bracco Imaging announced United States FDA 510(k) clearance and Health Canada authorization for VueJect, the company’s ultrasound contrast delivery system designed to support cardiology imaging.

REFORM-HF Pivotal Trial of Aquapass Eccon System for Fluid Overload Management Completes Enrollment

August 10, 2026—Aquapass, developer of a noninvasive, kidney-independent therapy for fluid overload management in patients experiencing heart failure and chronic or end-stage kidney disease, announced completion of enrollment in the FDA pivotal REFORM-HF trial for its Eccon system.

P&F Products & Features Acquires AVVie

August 7, 2026—P&F Products & Features GmbH, headquartered in Vienna, Austria, announced the acquisition of AVVie GmbH, developer of the AngelValve augmentation system, a transcatheter platform for the treatment of mitral valve disease in patients with limited or no treatment options.

SMARTFLOW Study of AngioInsight’s AngioAI+ Software Platform Begins Enrollment

August 7, 2026—AngioInsight Inc., a developer of artificial intelligence (AI)–powered cardiovascular diagnostics, announced the enrollment of the first patient in the SMARTFLOW clinical study of the company’s investigational AngioAI+ software platform.

Salus Scientific Closes Series A Financing to Support Occupational Wellness Platform

August 6, 2026—Salus Scientific Corporation announced the closing of its oversubscribed Series A financing, raising a total of $10.1 million.